| scholarly article | Q13442814 |
| P2093 | author name string | Baker DG | |
| Hill KK | |||
| West SA | |||
| Nicholson WE | |||
| Orth DN | |||
| Geracioti TD Jr | |||
| Kasckow JW | |||
| Ekhator NN | |||
| Bruce AB | |||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | battle | Q178561 |
| veteran | Q193891 | ||
| post-traumatic stress disorder | Q202387 | ||
| P304 | page(s) | 585-588 | |
| P577 | publication date | 1999-04-01 | |
| P1433 | published in | American Journal of Psychiatry | Q1935368 |
| P1476 | title | Serial CSF corticotropin-releasing hormone levels and adrenocortical activity in combat veterans with posttraumatic stress disorder | |
| P478 | volume | 156 |
| Q64974938 | A Comprehensive Overview on Stress Neurobiology: Basic Concepts and Clinical Implications. |
| Q21296643 | A Pilot Study of Mifepristone in Combat-Related PTSD |
| Q30494529 | Activation of raphe efferents to the medial prefrontal cortex by corticotropin-releasing factor: correlation with anxiety-like behavior |
| Q47157683 | Adaptive Changes in the Sensitivity of the Dorsal Raphe and Hypothalamic Paraventricular Nuclei to Acute Exercise, and Hippocampal Neurogenesis May Contribute to the Antidepressant Effect of Regular Treadmill Running in Rats |
| Q35591620 | Alterations in stress reactivity after long-term treatment with paroxetine in women with posttraumatic stress disorder |
| Q36728468 | Basolateral Amygdala and the Regulation of Fear-Conditioned Changes in Sleep: Role of Corticotropin-Releasing Factor |
| Q28189955 | Biologic findings of post-traumatic stress disorder and child maltreatment |
| Q30448609 | Biomarkers in posttraumatic stress disorder: overview and implications for future research |
| Q36302912 | Brain activation during fear conditioning in humans depends on genetic variations related to functioning of the hypothalamic-pituitary-adrenal axis: first evidence from two independent subsamples. |
| Q30474928 | CRF receptor blockade prevents initiation and consolidation of stress effects on affect in the predator stress model of PTSD |
| Q30480573 | CRF1 and CRF2 receptors are required for potentiated startle to contextual but not discrete cues |
| Q38247989 | Cardiac autonomic imbalance by social stress in rodents: understanding putative biomarkers |
| Q36569312 | Cerebrospinal fluid neuropeptide Y in combat veterans with and without posttraumatic stress disorder |
| Q26851378 | Childhood stressful events, HPA axis and anxiety disorders |
| Q35591603 | Childhood trauma associated with smaller hippocampal volume in women with major depression. |
| Q42482798 | Chronic administration of the triazolobenzodiazepine alprazolam produces opposite effects on corticotropin-releasing factor and urocortin neuronal systems. |
| Q55073721 | Closed Loop Deep Brain Stimulation for PTSD, Addiction, and Disorders of Affective Facial Interpretation: Review and Discussion of Potential Biomarkers and Stimulation Paradigms. |
| Q36161776 | Cognitive disruptions in stress-related psychiatric disorders: A role for corticotropin releasing factor (CRF). |
| Q30433266 | Combat posttraumatic stress disorder, substance use disorders, and traumatic brain injury |
| Q38859526 | Concurrent Treatment of Substance Use and PTSD. |
| Q30419977 | Connecting the pathology of posttraumatic stress and substance use disorders: monoamines and neuropeptides |
| Q35679975 | Consolidation of remote fear memories involves Corticotropin-Releasing Hormone (CRH) receptor type 1-mediated enhancement of AMPA receptor GluR1 signaling in the dentate gyrus. |
| Q38973504 | Context Processing and the Neurobiology of Post-Traumatic Stress Disorder |
| Q30481020 | Corticotropin releasing factor (CRF) modulates fear-induced alterations in sleep in mice |
| Q30502566 | Corticotropin releasing factor (CRF) receptor signaling in the central nervous system: new molecular targets |
| Q37373350 | Corticotropin releasing hormone receptor 2 (CRHR-2) gene is associated with decreased risk and severity of posttraumatic stress disorder in women |
| Q38631796 | Corticotropin-Releasing Factor Receptor 1 Antagonism Is Ineffective for Women With Posttraumatic Stress Disorder |
| Q30456196 | Corticotropin-releasing factor and noradrenergic signalling exert reciprocal control over startle reactivity |
| Q37445500 | Cortisol metabolic predictors of response to psychotherapy for symptoms of PTSD in survivors of the World Trade Center attacks on September 11, 2001. |
| Q30453359 | Cortisol suppression by dexamethasone reduces exaggerated fear responses in posttraumatic stress disorder |
| Q47903886 | Crossroads of corticotropin releasing hormone, corticosteroids and monoamines. About a biological interface between stress and depression |
| Q58613845 | DNA methylation levels are associated with CRF receptor antagonist treatment outcome in women with post-traumatic stress disorder |
| Q30477086 | Diurnal variation of the startle reflex in relation to HPA-axis activity in humans. |
| Q46815699 | Dopamine and corticotropin-releasing factor synergistically alter basolateral amygdala-to-medial prefrontal cortex synaptic transmission: functional switch after chronic cocaine administration |
| Q35172505 | Dysregulated hypothalamic-pituitary-adrenal axis function contributes to altered endocrine and neurobehavioral responses to acute stress |
| Q90398862 | Early Life Stress and Pediatric Posttraumatic Stress Disorder |
| Q92742329 | Early Life Stress as a Predictor of Co-Occurring Alcohol Use Disorder and Post-Traumatic Stress Disorder |
| Q48653936 | Effect of paroxetine on enhanced contextual fear induced by single prolonged stress in rats |
| Q30462225 | Effects of corticotropin releasing factor (CRF) on sleep and body temperature following controllable footshock stress in mice |
| Q30404807 | Effects of corticotropin releasing factor (CRF) on sleep and temperature following predictable controllable and uncontrollable stress in mice |
| Q36294439 | Effects of posttraumatic stress disorder on pregnancy outcomes |
| Q28083141 | Emerging drugs for the treatment of anxiety |
| Q21129110 | Epigenetic Risk Factors in PTSD and Depression |
| Q37663644 | Epigenetic modulation of glucocorticoid receptors in posttraumatic stress disorder. |
| Q30394729 | Epigenetics and memory: causes, consequences and treatments for post-traumatic stress disorder and addiction |
| Q30434663 | Evaluation of a corticotropin releasing hormone type 1 receptor antagonist in women with posttraumatic stress disorder: study protocol for a randomized controlled trial |
| Q36108328 | Fear conditioning and early life vulnerabilities: two distinct pathways of emotional dysregulation and brain dysfunction in PTSD |
| Q30474991 | Fear potentiation is associated with hypothalamic-pituitary-adrenal axis function in PTSD |
| Q30413232 | Forebrain-specific CRF overproduction during development is sufficient to induce enduring anxiety and startle abnormalities in adult mice |
| Q30370972 | GABA and NMDA receptors in CRF neurons have opposing effects in fear acquisition and anxiety in central amygdala vs. bed nucleus of the stria terminalis. |
| Q36826920 | Glucocorticoid hyper- and hypofunction: stress effects on cognition and aggression. |
| Q38991472 | HPA Axis Interactions with Behavioral Systems |
| Q30465311 | Hydrocortisone suppression of the fear-potentiated startle response and posttraumatic stress disorder |
| Q30480711 | Increased anxiety during anticipation of unpredictable aversive stimuli in posttraumatic stress disorder but not in generalized anxiety disorder. |
| Q34491885 | Induction and Expression of Fear Sensitization Caused by Acute Traumatic Stress |
| Q35018476 | Inflammation and oxidative stress are elevated in the brain, blood, and adrenal glands during the progression of post-traumatic stress disorder in a predator exposure animal model |
| Q50055963 | Inflammatory parameters in sexually abused children |
| Q34159604 | Interaction of FKBP5 with childhood adversity on risk for post-traumatic stress disorder |
| Q30459612 | Interactions between corticotropin-releasing factor and the serotonin 1A receptor system on acoustic startle amplitude and prepulse inhibition of the startle response in two rat strains |
| Q36575179 | Low cerebrospinal fluid neuropeptide Y concentrations in posttraumatic stress disorder |
| Q35415126 | Magnesium deficiency induces anxiety and HPA axis dysregulation: modulation by therapeutic drug treatment |
| Q46055081 | MicroRNAs in Post-traumatic Stress Disorder |
| Q47207303 | Microbiota Modulate Anxiety-Like Behavior and Endocrine Abnormalities in Hypothalamic-Pituitary-Adrenal Axis |
| Q30452038 | Missing and Possible Link between Neuroendocrine Factors, Neuropsychiatric Disorders, and Microglia |
| Q34167844 | Modeling cortisol dynamics in the neuro-endocrine axis distinguishes normal, depression, and post-traumatic stress disorder (PTSD) in humans |
| Q47931276 | Molecular and Cellular Effects of Traumatic Stress: Implications for PTSD. |
| Q26860173 | Molecular and cell signaling targets for PTSD pathophysiology and pharmacotherapy |
| Q89665986 | Multilevel Interactions of Stress and Circadian System: Implications for Traumatic Stress |
| Q89600790 | Nervous and Endocrine System Dysfunction in Posttraumatic Stress Disorder: An Overview and Consideration of Sex as a Biological Variable |
| Q27026217 | Neural regulation of the stress response: glucocorticoid feedback mechanisms |
| Q30473432 | Neurobiological findings in posttraumatic stress disorder: a review |
| Q37160664 | Neurodevelopmental Biology Associated with Childhood Sexual Abuse |
| Q36108739 | Neuroendocrine and immune responses to a cognitive stress challenge in veterans with and without PTSD. |
| Q27030562 | Neuropeptide Y and posttraumatic stress disorder |
| Q57175620 | Neurotransmitter, Peptide, and Steroid Hormone Abnormalities in PTSD: Biological Endophenotypes Relevant to Treatment |
| Q30494165 | Nitric oxide as inflammatory mediator in post-traumatic stress disorder (PTSD): evidence from an animal model. |
| Q34288849 | Novelty-evoked activity in open field predicts susceptibility to helpless behavior. |
| Q24633134 | PTSD and gene variants: new pathways and new thinking. |
| Q90220218 | Persistent Stress-Induced Neuroplastic Changes in the Locus Coeruleus/Norepinephrine System |
| Q39005149 | Pharmacogenetics and Pharmacotherapy of Military Personnel Suffering from Post-traumatic Stress Disorder. |
| Q24633256 | Pharmacological treatment of PTSD – Established and new approaches |
| Q36829455 | Pharmacotherapy of PTSD: Current Status and Controversies |
| Q90734129 | Pituitary Adenylate Cyclase-Activating Peptide (PACAP) Signaling and the Dark Side of Addiction |
| Q35237340 | Post-traumatic stress disorder and declarative memory functioning: a review |
| Q35003793 | Post-traumatic stress disorder in women: current concepts and treatments |
| Q34317705 | Post-traumatic stress disorder: a review of recent findings |
| Q34981801 | Post-traumatic stress disorder: emerging concepts of pharmacotherapy |
| Q93130750 | Posttraumatic Stress Disorder Is Associated with Increased Risk of Ovarian Cancer: A Prospective and Retrospective Longitudinal Cohort Study |
| Q30385449 | Predator Stress-Induced CRF Release Causes Enduring Sensitization of Basolateral Amygdala Norepinephrine Systems that Promote PTSD-Like Startle Abnormalities. |
| Q34053512 | Pregnant women with posttraumatic stress disorder and risk of preterm birth |
| Q39848013 | Putative biological mechanisms for the association between early life adversity and the subsequent development of PTSD. |
| Q28364782 | Recent advances: Psychiatry |
| Q30442231 | Recent progress in understanding the pathophysiology of post-traumatic stress disorder: implications for targeted pharmacological treatment |
| Q27004411 | Relations among posttraumatic stress disorder, comorbid major depression, and HPA function: A systematic review and meta-analysis |
| Q34865829 | Resilience to the effects of social stress: evidence from clinical and preclinical studies on the role of coping strategies |
| Q30458749 | Review of biological mechanisms and pharmacological treatments of comorbid PTSD and substance use disorder |
| Q30482099 | Risk and resilience: genetic and environmental influences on development of the stress response. |
| Q30498732 | Role of corticotropin releasing factor in anxiety disorders: a translational research perspective |
| Q28589225 | Role of dopamine D1 and D2 receptors in CRF-induced disruption of sensorimotor gating |
| Q26991739 | Role of kappa-opioid receptors in stress and anxiety-related behavior |
| Q64071408 | Role of the Bed Nucleus of the Stria Terminalis in PTSD: Insights From Preclinical Models |
| Q64939007 | Role of the posterodorsal medial amygdala in predator odour stress-induced puberty delay in female rats. |
| Q37398297 | Salivary cortisol is associated with diagnosis and severity of late-life generalized anxiety disorder |
| Q36044962 | Sex differences in molecular and cellular substrates of stress. |
| Q47854333 | Sex differences in neurosteroid and hormonal responses to metyrapone in posttraumatic stress disorder |
| Q33864552 | Sex differences in stress-related psychiatric disorders: neurobiological perspectives |
| Q36565231 | Sex differences in stress-related receptors: ″micro″ differences with ″macro″ implications for mood and anxiety disorders |
| Q36717095 | Sex-biased stress signaling: the corticotropin-releasing factor receptor as a model |
| Q30410039 | Sleep and REM sleep disturbance in the pathophysiology of PTSD: the role of extinction memory |
| Q47651707 | Sleep and hypothalamic pituitary adrenal axis responses to metyrapone in posttraumatic stress disorder |
| Q36298093 | Sleep disturbances and PTSD: a perpetual circle? |
| Q33262080 | Stress and brain atrophy |
| Q22305696 | Stress risk factors and stress-related pathology: neuroplasticity, epigenetics and endophenotypes |
| Q35580511 | Structural and functional plasticity of the human brain in posttraumatic stress disorder |
| Q92521739 | The 24-hour urinary cortisol in post-traumatic stress disorder: A meta-analysis |
| Q30454302 | The CRF system, stress, depression and anxiety-insights from human genetic studies |
| Q48274036 | The CRF1 receptor antagonist R121919 attenuates the neuroendocrine and behavioral effects of precipitated lorazepam withdrawal |
| Q44988100 | The CRF₁ receptor antagonist SSR125543 prevents stress-induced cognitive deficit associated with hippocampal dysfunction: comparison with paroxetine and D-cycloserine |
| Q30387331 | The CRH1 antagonist GSK561679 increases human fear but not anxiety as assessed by startle |
| Q33398794 | The association of posttraumatic stress disorder and metabolic syndrome: a study of increased health risk in veterans |
| Q37669920 | The biological effects of childhood trauma |
| Q35653169 | The darkness within: individual differences in stress |
| Q42102059 | The expression of corticotropin-releasing factor in the central nucleus of the amygdala, induced by colorectal distension, is attenuated by general anesthesia |
| Q37574667 | The neurobiological toll of child abuse and neglect. |
| Q30473425 | The psychobiology of resilience and vulnerability to anxiety disorders: implications for prevention and treatment |
| Q30429995 | The role of PKC signaling in CRF-induced modulation of startle |
| Q35974568 | The role of cortisol in PTSD among women exposed to a trauma-related stressor |
| Q52623796 | The role of suboptimal mitochondrial function in vulnerability to post-traumatic stress disorder |
| Q42682241 | The serotonergic projection from the median raphe nucleus to the ventral hippocampus is involved in the retrieval of fear memory through the corticotropin-releasing factor type 2 receptor |
| Q41592543 | Traits of fear resistance and susceptibility in an advanced intercross line. |
| Q31099484 | Traumatic stress: effects on the brain |
| Q34175227 | Using high resolution imaging to determine trafficking of corticotropin-releasing factor receptors in noradrenergic neurons of the rat locus coeruleus. |
Search more.